ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
Provided By GlobeNewswire
Last update: Aug 15, 2024
• Executed Global Licensing Agreements that could provide up to $292 million in income
• Received Cash Milestone Incomes of $116,000
Read more at globenewswire.com0.6996
+0.11 (+19.59%)
Find more stocks in the Stock Screener
ABVC Latest News and Analysis
2 days ago - ChartmillOn Friday, there are stocks with unusual volume. Let's take a look.The trading volume of these stocks is deviating from the norm in today's session.
